Global Nicotine Replacement Therapy (NRT) Products Market Research Report 2022

Nicotine replacement therapy (NRT) is a medically-approved way to take nicotine by means other than tobacco. It is used to help with quitting smoking or stopping chewing tobacco. It increases the chance of quitting smoking by about 50% to 70%.Often it is used along with other behavioral techniques. NRT has also been used to treat ulcerative colitis. Types of NRT include the adhesive patch, chewing gum, lozenges, nose spray, and inhaler. The use of more than one type of NRT at a time may increase effectiveness.
Due to the COVID-19 pandemic, the global Nicotine Replacement Therapy (NRT) Products market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Nicotine Replacement Therapy (NRT) Products market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Nicotine Replacement Therapy (NRT) Products landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Sprays accounting for % of the Nicotine Replacement Therapy (NRT) Products global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Individual segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Nicotine Replacement Therapy (NRT) Products include GSK, Perrigo Company, Pfizer, Fertin Pharma, Revolymer, Johnson & Johnson, Cambrex Corporation, Reynolds American and Dr. Reddy’s Laboratories, etc. In terms of revenue, the global 3 largest players have a % market share of Nicotine Replacement Therapy (NRT) Products in 2021.
This report focuses on Nicotine Replacement Therapy (NRT) Products volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Nicotine Replacement Therapy (NRT) Products market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Nicotine Replacement Therapy (NRT) Products Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Sprays
Inhalers
Chewing Gums
Transdermal Patches
Others
Segment by Application
Individual
Hospital
Withdrawal Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
GSK
Perrigo Company
Pfizer
Fertin Pharma
Revolymer
Johnson & Johnson
Cambrex Corporation
Reynolds American
Dr. Reddy’s Laboratories
Strides Consumer Private Limited
Kind Consumer
MicromistNOW

Frequently Asked Questions